Press release – For immediate release
September 6, 2022 – 5:45 p.m. CEST
Median Technologies will make two presentations regarding iCRO and iBiopsy® at the ESMO 2022 Congress from September 9 to 13 in Paris
• iCRO: presentation of a scientific poster on September 10: “Challenges to Assess Bone Metastases in Blinded Independent Central Review (BICR) of Breast Cancer Trials Using RECIST 1.1”
• iBiopsy®: presentation of a scientific poster on September 11: “Artificial Intelligence Supporting Lung Cancer Screening: Computer Aided Diagnosis of Lung Lesions Driven by Morphological Feature Extraction”
• The Median team will be present on stand 447, Hall 7.2 for the duration of the technical exhibition
Sophia Antipolis, France – Median Technologies (ALMDT) announces today its participation in the annual congress of the ESMO (European Society for Medical Oncology) which will be held from September 9 to 13 in Paris (Paris Expo Porte de Versailles).
Median will present two scientific posters there.